Some COX-2 inhibitors, such as celecoxib were even used for the prevention of familial adenomatous polyposis (FAP), which represents a major risk factor for colorectal cancer (CRC) development [10]. The gene discussed is PTGS2; the disease is Familial adenomatous polyposis.